AI app aims to keep young hearts healthy after hospital discharge
NCT ID NCT07031531
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing whether an AI-driven system called SMART-CHD can improve outcomes for adults aged 18-45 with premature coronary artery disease. Participants will use a mobile app and wearable sensors to track their health and receive personalized guidance. The goal is to see if this approach reduces the risk of death, heart attack, stroke, or rehospitalization compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-Enabled Stratified Management System (SMART-CHD mobile app and paired wearable sensors)
- What this could lead to
- If successful, this could provide a scalable, personalized way for young heart disease patients to better control risk factors and reduce hospital readmissions.
- What could go wrong
- This is a relatively early-stage trial without a prior phase, and the intervention relies heavily on patient engagement and technology adherence. Results may not generalize to less tech-savvy populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE CORONARY HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
NOT_YET_RECRUITINGShenzhen, Guangdong, 518057, China
-
Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases
RECRUITINGBeijing, Beijing Municipality, 100037, China
-
Henan Provincial Chest Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450000, China
-
Northern Jiangsu People's Hospital
NOT_YET_RECRUITINGYangzhou, Jiangsu, 225001, China
-
Shanxi Cardiovascular Disease Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, 030024, China
-
The Affiliated Hospital of Southwest Medical University
NOT_YET_RECRUITINGLuzhou, Sichuan, 400042, China
-
The First Affiliated Hospital of Henan University of Science and Technology
NOT_YET_RECRUITINGLuoyang, Henan, 471003, China
-
The First Affiliated Hospital of Nanjing Medical University
NOT_YET_RECRUITINGNanjing, Jiangsu, 210029, China
-
The First Affiliated Hospital of University of Science and Technology of China
NOT_YET_RECRUITINGHefei, Anhui, 230001, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITINGXi'an, Shaanxi, 710061, China
-
The First Hospital of Hebei Medical University
NOT_YET_RECRUITINGShijiazhuang, Hebei, 050000, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITINGXi'an, Shaanxi, 710004, China
-
The Second Affiliated Hospital, School of Medicine, Zhejiang University
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310009, China
-
The Second Hospital Of Hebe Medical University
NOT_YET_RECRUITINGShijiazhuang, Hebei, 050000, China
-
Zhengzhou University Affiliated Zhengzhou Central Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450000, China
-
Zhengzhou University Fuwai Central China Cardiovascular Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.